CTS二季度业绩会重申上调2026年收入和调整后EPS指引

Earnings Call Insights: CTS Corporation (CTS) Q2 2026
"As I begin my first earnings call as CEO, I want to thank Kieran O'Sullivan for his leadership and the strong foundation he built at CTS." (President, CEO & Director Pratik Trivedi) "The Evolution 2030 strategy and our focus on diversification remains central to our value creation." (President, CEO & Director Trivedi)
"We delivered a strong second quarter with revenue growing 7% to $145 million." (President, CEO & Director Trivedi) "Our diversified end markets increased 15% year-over-year and represented 59% of total sales." (President, CEO & Director Trivedi) "While the quarter benefited from certain unusual items that contributed approximately $0.07 of favorable EPS impact, we still delivered record earnings per share." (President, CEO & Director Trivedi)
"In Transportation, we secured several new business awards, adding up to $163 million." (President, CEO & Director Trivedi) "Total booked business was approximately $1.2 billion at the end of the quarter, up approximately $100 million from the first quarter." (President, CEO & Director Trivedi)
"We generated strong operating cash flow of $33 million in the second quarter." (VP & CFO Ashish Agrawal) "Capital expenditures were $4.6 million in the quarter and free cash flow was approximately $29 million." (VP & CFO Agrawal) "Our balance sheet strengthened further with a cash balance of $108 million and borrowings of $55 million at the end of the quarter." (VP & CFO Agrawal)
"Assuming the continuation of current market conditions for full year 2026, we are raising our guidance with sales now expected in the range of $565 million to $585 million and adjusted diluted EPS in the range of $2.55 to $2.70." (President, CEO & Director Trivedi)
"Across transportation markets, global light vehicle production volumes are forecasted to be flat to modestly down given ongoing tariff, geopolitical and consumer demand uncertainties." (President, CEO & Director Trivedi) "We expect the commercial vehicle market to have modest growth, supported by improving freight fundamentals and prebuy activity ahead of upcoming emissions regulations." (President, CEO & Director Trivedi)
"Second quarter sales were $144.8 million, up 7% compared to the second quarter of 2025, and up 4% sequentially from the first quarter of 2026." (VP & CFO Agrawal) "Foreign currency changes impacted sales favorably by approximately $1.4 million in the quarter." (VP & CFO Agrawal)
"Our adjusted gross margin was a record 41.5%." (VP & CFO Agrawal) "Adjusted EBITDA margin was 25.4%." (VP & CFO Agrawal) "Our effective tax rate for the quarter was 21.8%, excluding discrete items." (VP & CFO Agrawal)
"Adjusted earnings for the second quarter were a record $0.74 per diluted share." (VP & CFO Agrawal) "As Pratik mentioned earlier, our results this quarter included foreign currency favorability, as well as a larger customer reimbursement." (VP & CFO Agrawal) "These items add up to approximately $0.07 of favorable EPS impact." (VP & CFO Agrawal)
"During the quarter, we repurchased approximately 64,000 shares of CTS stock for $3.5 million." (VP & CFO Agrawal) "We have $78 million remaining under our current share repurchase program." (VP & CFO Agrawal)
John Franzreb, Sidoti & Company, LLC: asked how the new CEO may differ from his predecessor; President, CEO & Director Trivedi said, "what we are trying to work towards is an acceleration of our growth strategy across the diversified end markets, at the same time, stabilizing our transportation business."
John Franzreb, Sidoti & Company, LLC: asked whether the R&D reimbursement should normalize; VP & CFO Agrawal said, "we do expect the R&D expenses to normalize going forward," while adding, "that doesn't mean we don't have any more customer reimbursements."
John Franzreb, Sidoti & Company, LLC: asked about medical margins; VP & CFO Agrawal said, "Medical would definitely be stronger of all the diversified end markets, but we have pretty healthy margins in industrial and aerospace and defense as well."
John Franzreb, Sidoti & Company, LLC: asked whether medical capacity expansion is complete; President, CEO & Director Trivedi said, "yes, that has already been in place," and added, "we do expect, especially in the therapeutics application, volumes start to get more normalized in the second half of the year."
Hendi Susanto, Gabelli Funds, LLC: asked about pricing actions vs. inflation and tariffs; VP & CFO Agrawal said, "The range of EPS estimate for the second half" reflects outcomes where "on the higher end, we would be looking to have some positive outcome" and "on the lower end, we may be seeing more cost pressure."
Hendi Susanto, Gabelli Funds, LLC: asked what drives the higher revenue outlook; President, CEO & Director Trivedi said diversified end markets are expected to continue "across all three of the end markets," while transportation reflects "a cautious stance on the light vehicle production trends."
John Franzreb, Sidoti & Company, LLC: asked if transportation book-to-bill was below 1; VP & CFO Agrawal said, "It's close to 1," and added that transportation orders are "very short cycle" so book-to-bill is "not a good representation."
John Franzreb, Sidoti & Company, LLC: asked about commercial vehicle exposure and second-half demand; President, CEO & Director Trivedi said CTS models "a modest growth in the second half of the year" driven by "rising freight rates" and "a potential prebuy" tied to "the EPA 2027 emission change," while VP & CFO Agrawal added, "we are also working through the second source that was launched by Cummins" and expect "visibility towards the end of the year."
John Franzreb, Sidoti & Company, LLC: asked whether returning transportation volume could pressure margins; VP & CFO Agrawal said, "whenever you're launching a new program, the gross margin could be a little bit under pressure," followed by productivity actions "through the life cycle."
Slightly negative analyst tone, centered on sustainability and puts/takes: questions pressed on one-time items (FX/reimbursements), the timing/benefit of pricing actions vs. cost inflation, and transportation bookings and margin sensitivity, including "does that suggest the book-to-bill in Transportation was below 1.0" (John Franzreb, Sidoti & Company, LLC).
Slightly positive management tone with targeted caution on external variables: leadership emphasized momentum and raised guidance, while repeatedly framing uncertainty as ranges and monitoring, including "We continue to monitor and evaluate the tariff and geopolitical environment" (President, CEO & Director Trivedi) and "It's going to a range of outcomes" (VP & CFO Agrawal).
Compared with Q1, management language in Q2 leaned more confident on execution (record margins/raised guidance) while keeping a similar caution framework on tariffs and transportation volumes; analysts stayed focused on mix/margins and transportation visibility in both quarters.
Leadership and emphasis shifted: Q1 prepared remarks were led by "Chairman, President & CEO Kieran O'Sullivan"; Q2 opened with "my first earnings call as CEO" (President, CEO & Director Trivedi) and a stated intent to "accelerat[e]" diversified growth while "stabilizing" transportation.
Guidance moved higher quarter-over-quarter: Q1 guided "sales guidance in the range of $560 million to $580 million" and "adjusted diluted EPS" of "$2.35 to $2.45" (Chairman, President & CEO Kieran O'Sullivan); Q2 raised to "$565 million to $585 million" and "$2.55 to $2.70" (President, CEO & Director Trivedi).
End-market narrative evolved: Q1 described aerospace and defense bookings as down with funding expected to improve in the second half; Q2 again pointed to funding timing but added "we are beginning to see government funding flow" and "expect a stronger second half of the year" (President, CEO & Director Trivedi).
"We continue to closely monitor and evaluate the tariff and geopolitical environment, including the new tariff announcements last week." (President, CEO & Director Trivedi) "We are not anticipating any material impact from the recent tariff announcements and will monitor further developments." (President, CEO & Director Trivedi)
"We continue to monitor the impact of Section 232 tariff changes, precious metal inflation and input cost pressures." (VP & CFO Agrawal) "our teams are partnering with customers and suppliers to keep the effect on our margins broadly cost neutral." (VP & CFO Agrawal)
"Aerospace and Defense sales were $18 million in the second quarter, down 15% year-over-year" and reflected "the timing of program funding and government contract awards." (President, CEO & Director Trivedi)
CTS’s new CEO emphasized that Evolution 2030 and diversification remain central, highlighting record profitability and cash generation in Q2 alongside sizeable transportation awards and a higher total booked business figure. Management raised full-year 2026 guidance for both sales and adjusted diluted EPS, while repeatedly flagging tariffs, input costs, and transportation production uncertainty as key swing factors embedded in the second-half earnings range, and positioning aerospace and defense for a stronger second half as funding flow and program activity improve.